These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36884334)

  • 1. Buprenorphine versus Methadone in Pregnancy.
    McCarthy JJ
    N Engl J Med; 2023 Mar; 388(10):957. PubMed ID: 36884334
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine versus Methadone in Pregnancy. Reply.
    Suarez EA; Huybrechts KF; Bateman BT
    N Engl J Med; 2023 Mar; 388(10):957-958. PubMed ID: 36884335
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine: a more accessible treatment for opioid dependence.
    Flassing J
    JAAPA; 2010 Sep; 23(9):40-3. PubMed ID: 20845653
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors associated with buprenorphine versus methadone use in pregnancy.
    Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
    Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone and buprenorphine treatments in patients with schizophrenia.
    Dervaux A; Plancke L; Amariei A; Trouiller P; Tahon M; Martinetti MP; Naassila M; Cottencin O; Danel T
    Schizophr Res; 2019 Jul; 209():286-288. PubMed ID: 31101511
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
    Zedler BK; Mann AL; Kim MM; Amick HR; Joyce AR; Murrelle EL; Jones HE
    Addiction; 2016 Dec; 111(12):2115-2128. PubMed ID: 27223595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal assessment before and after dosing with buprenorphine or methadone.
    Salisbury AL; Coyle MG; O'Grady KE; Heil SH; Martin PR; Stine SM; Kaltenbach K; Weninger M; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):36-44. PubMed ID: 23106925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.
    Konijnenberg C; Melinder A
    Child Neuropsychol; 2011; 17(5):495-519. PubMed ID: 21480011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine.
    Holbrook AM; Baxter JK; Jones HE; Heil SH; Coyle MG; Martin PR; Stine SM; Kaltenbach K
    Addiction; 2012 Nov; 107 Suppl 1(Suppl 1):83-90. PubMed ID: 23106930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
    Riksheim M; Gossop M; Clausen T
    J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone and buprenorphine: The search for a non-addictive opioid.
    Ball CM; Featherstone PJ
    Anaesth Intensive Care; 2022 Mar; 50(1-2):4-7. PubMed ID: 35170338
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.